-transparent.png){kind=logo}
Recent reports of hepatitis A virus (HAV) infection in haemophiliacs receiving high-purity solvent detergent (HP.SD) treated factor VIII concentrates have brought into question the efficacy of this virucidal method for inactivating HAV. To assess whether HAV may have been transmitted by HP.SD concentrates, we compared seroprevalence in haemophiliacs with different disease severity, sought evidence of seroconversion to HAV since introduction of HP.SD products, and directly examined concentrates for HAV RNA by PCR. Our data suggest that Scottish haemophiliacs are not being infected with HAV by HP.SD concentrates produced initially by CRTS Lille and presently by PFC Edinburgh and supplied by the Scottish National Blood Transfusion Service (SNBTS).
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
December 2020,
Emerging infectious diseases,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
May 1994,
Journal of medical virology,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
October 1999,
Transfusion,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
January 1994,
Vox sanguinis,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
September 2008,
Biologicals : journal of the International Association of Biological Standardization,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
January 1991,
Vox sanguinis,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
October 1990,
Lancet (London, England),
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
March 1994,
Lancet (London, England),
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
May 2007,
Vox sanguinis,
H G Watson, and
C A Ludlam, and
F McOmish, and
R Dennis, and
H Hart, and
P Simmonds
October 1993,
Lancet (London, England),
